Examples of Loxapine in a sentence
Loxapine is currently available in an oral formulation in the U.S. for the management of the manifestations of schizophrenia.
Alexza is a pharmaceutical development company focused on the research, development, manufacturing and commercialization of novel proprietary products for the acute treatment of central nervous system disorders based on its proprietary technology, the Staccato® system, and has developed and obtained FDA approval for a drug-device combination product that is comprised of Loxapine (as defined hereinafter) delivered by a Staccato Device (as defined hereinafter), and approved under the trade name “Adasuve”.
For the avoidance of doubt, the license granted to BLS under Section 2.1 does not confer any rights to BLS with respect to any product comprising the Device and any API other than Loxapine, or any product comprising the Device and Loxapine together with one or more other API(s).
During the Term of this Agreement, Alexza shall use Commercially Reasonable Efforts to prevent (as to itself and its Affiliates), and shall include and enforce contractual obligations on its other licensees, sublicensees and distributors of the Product to use Commercially Reasonable Efforts to prevent, any and all off-label uses of the Product or any combination product that is comprised of Loxapine and one or more other APIs delivered by the Device in the Field in the Territory.
NEWS RELEASE — for immediate release Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato® Loxapine) in North America Conference Call Scheduled for Tomorrow - Wednesday, February 10, 2010 at 8:30 a.m. Eastern Time Mountain View, California — February [9], 2010 - Alexza Pharmaceuticals, Inc.
BLS may terminate this Agreement in its entirety at any time during the Term upon ninety (90) days prior written notice to Alexza if there has been a [ * ] recall of the Product, provided that such recall is the direct result of (i) the negligence or willful misconduct of Alexza, (ii) a material breach of the Supply Agreement by Alexza or (iii) the manufacture of the Product, Loxapine or other components of the Product by or on behalf of Alexza.
One of the Company’s programs consists of Phase III testing of the Staccato system for delivery of the drug Loxapine in mitigating the effects of acute agitation in schizophrenia or bipolar disorder and, in a separate program, Phase II testing of Loxapine for the treatment of migraine headaches.
Alexza is a pharmaceutical development company focused on the research, development, manufacturing and commercialization of novel proprietary products for the acute treatment of central nervous system disorders based on its proprietary technology, the Staccato® system, and is developing a combination product that is comprised of Loxapine (as defined hereinafter) delivered by a proprietary device.
If Alexza does not exercise the purchase option by December 1, 2010, then the Company will retain its exclusive license to develop and commercialize Staccato Alprazolam and Staccato Loxapine for all indications, and Alexza will maintain exclusive rights to manufacture and sell Staccato Alprazolam and Staccato Loxapine to the Company or its sublicensee for those purposes.
For the avoidance of doubt, rights reserved by Alexza hereunder do not include any of Teva’s rights to [ * ], and the licenses granted to Teva under Section 2.1 do not confer any rights to Teva with respect to any product comprising the Staccato Device and any API other than Loxapine, or any product comprising the Staccato Device and two or more APIs that do not include Loxapine.